Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03843047 · ClinicalTrials.gov registry record · NA

Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace

A NA study, sponsored by Virginia Polytechnic Institute and State University.

Completed
Registry status
NA
Development phase
81
Enrollment target

NCT03843047 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 81 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03843047, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target

Study Summary

Electronic cigarettes (e-cigarettes) may be a safer alternative to conventional cigarettes and are available in a broad range of nicotine strengths. The overall goal of this project is to use an experimental analogue of the real-world tobacco marketplace to examine the effects of nicotine strength on e-cigarette consumption and the likelihood that current smokers will either switch to e-cigarettes (which may reduce harm) or use both products in combination (which may increase harm). Testing effects of e-cigarette nicotine strength under controlled conditions in a context that models the real world will facilitate evidence-based policies that have a net benefit to health.

Interventions

  • DRUG 3 mg/mL nicotine strength e-liquid
  • DRUG 6 mg/mL nicotine strength e-liquid
  • DRUG 12 mg/mL nicotine strength e-liquid
  • DRUG 24 mg/mL nicotine strength e-liquid

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2019-03-01
Est. Completion 2021-09-30
Phase NA

What the Registry Record Tells You About NCT03843047

The ClinicalTrials.gov registry entry for NCT03843047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which 3 mg/mL nicotine strength e-liquid is the first listed.

NCT03843047 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03843047 about?

NCT03843047 is a clinical study titled "Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace". Electronic cigarettes (e-cigarettes) may be a safer alternative to conventional cigarettes and are available in a broad range of nicotine strengths. The overall goal of this project is to use an experimental analogue of the real-world tobacco marketplace to examine the effects of nicotine strength o...

What is the current status of trial NCT03843047?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2019-03-01. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT03843047?

The interventions under investigation include: 3 mg/mL nicotine strength e-liquid (DRUG), 6 mg/mL nicotine strength e-liquid (DRUG), 12 mg/mL nicotine strength e-liquid (DRUG), 24 mg/mL nicotine strength e-liquid (DRUG).

Who is sponsoring clinical trial NCT03843047?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.